首页    期刊浏览 2024年11月08日 星期五
登录注册

文章基本信息

  • 标题:Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease
  • 本地全文:下载
  • 作者:Jean-Pascal De Bandt ; Prasanthi Jegatheesan ; Naouel Tennoune-El-Hafaia
  • 期刊名称:Nutrients
  • 电子版ISSN:2072-6643
  • 出版年度:2018
  • 卷号:10
  • 期号:9
  • 页码:1195-1205
  • DOI:10.3390/nu10091195
  • 出版社:MDPI Publishing
  • 摘要:Recent publications highlight a frequent loss of muscle mass in chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD), and its association with a poorer prognosis. In NAFLD, given the role of muscle in energy metabolism, muscle loss promotes disease progression. However, liver damage may be directly responsible of this muscle loss. Indeed, muscle homeostasis depends on the balance between peripheral availability and action of anabolic effectors and catabolic signals. Moreover, insulin resistance of protein metabolism only partially explains muscle loss during NAFLD. Interestingly, some data indicate specific alterations in the liver–muscle axis, particularly in situations such as excess fructose/sucrose consumption, associated with increased hepatic de novo lipogenesis (DNL) and endoplasmic reticulum stress. In this context, the liver will be responsible for a decrease in the peripheral availability of anabolic factors such as hormones and amino acids, and for the production of catabolic effectors such as various hepatokines, methylglyoxal, and uric acid. A better understanding of these liver–muscle interactions could open new therapeutic opportunities for the management of NAFLD patients.
  • 关键词:sarcopenia; protein metabolism; insulin resistance; endoplasmic reticulum stress; hepatokine; amino acid; uric acid; methylglyoxal sarcopenia ; protein metabolism ; insulin resistance ; endoplasmic reticulum stress ; hepatokine ; amino acid ; uric acid ; methylglyoxal
国家哲学社会科学文献中心版权所有